Corsair Pharma, a clinical-stage biopharma company based in Newark, California, collaborated with our agency to develop a new website on a short timeline ahead of a major PH conference presentation.
Its new digital presence would need patient-focused storytelling, everyday lifestyle imagery, and streamlined biotech branding. The goal of the website was to make a transdermal drug delivery mechanism feel approachable to patients, credible to treating physicians, and compelling to investors, all without overpromising on what the therapy could realistically deliver.
Immediately after our kickoff, our designer began building homepage concepts directly from the draft copy, allowing the site’s design and messaging to develop side by side.
Photography played a central role in the design. Our designer introduced a rotating collection of everyday lifestyle photography, rather than clinical or hospital imagery, centered on the line “Drug Delivery Designed for Daily Life.”
Corsair’s leadership required that the site reflect patients being treated earlier in the disease, not the more severe imagery often associated with PAH.
The result is a healthcare website that builds patient trust and investor confidence while meeting the client’s tight launch deadline.
The new early-stage biopharma website includes:
The redesigned website gives Corsair Pharma a platform to communicate its science, its patients, and its progress. It was launched in time to make a strong impression at the company’s most important conference appearance, and it creates an engaging experience for every visitor.
